S&P 500

5.304,72

0,70%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Progen Industries (PGLAF)
Progen Industries (PGLAF) Notícias

PGLAF

Progen (PGLAF)

Progen Industries

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PGLAF

1

Data	Hora	Fonte	Título	Código	Companhia
16/05/2006	07:53	PR Newswire (US)	Progen Prepares for Accelerated Clinical Development of PI-88 Following FDA Meeting	NASDAQ:PGLAF	Progen Industries
09/08/2005	08:00	PR Newswire (US)	Progen Expand PI-88 Clinical Development to Prostate Cancer	NASDAQ:PGLAF
28/06/2005	02:28	PR Newswire (US)	Progen Engages Burrill to Advance PI-88 Partnering Discussions	NASDAQ:PGLAF
17/05/2005	01:14	PR Newswire (US)	Results of PI-88 Phase II Clinical Trial in Melanoma Presented at ASCO	NASDAQ:PGLAF	Progen Industries
27/08/2004	01:53	PR Newswire (US)	Progen Reports Solid Financial Performance	NASDAQ:PGLAF	Progen Industries
14/07/2004	00:36	PR Newswire (US)	PI-88 Phase II Clinical Trial Targeting Liver Cancer Launched	NASDAQ:PGLAF	Progen Industries
03/05/2004	23:49	PR Newswire (US)	U.S. FDA Grants Orphan Drug Status to PI-88 for Melanoma	NASDAQ:PGLAF
27/02/2004	08:00	PR Newswire (US)	Half Year Report - Progen on Track to Meet Milestones	NASDAQ:PGLAF
11/02/2004	02:48	PR Newswire (US)	Progen Commences Third PI-88 Phase II Trial	NASDAQ:PGLAF	Progen Industries
19/11/2003	01:20	PR Newswire (US)	Bonus Issue of Options - Record Date November 28 2003	NASDAQ:PGLAF	Progen Industries
10/11/2003	23:58	PR Newswire (US)	Progen Sharpens Cancer Focus Through Divestment	NASDAQ:PGLAF
31/10/2003	04:43	PR Newswire (US)	Progen Industries Limited New Placement Terms Announced	NASDAQ:PGLAF	Progen Industries
31/10/2003	04:30	PR Newswire (US)	Progen Industries Limited Annual General Meeting	NASDAQ:PGLAF
28/10/2003	23:42	PR Newswire (US)	Progen Granted Anti-Angiogenesis Antibody Patent	NASDAQ:PGLAF	Progen Industries